Article Details
Retrieved on: 2021-01-08 18:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Cavrotolimod is designed to activate a potent anti-tumor immune response, to enhance the effectiveness of anti-PD-1 immune checkpoint inhibitors.
Article found on: immuno-oncologynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here